Works in Progress argues that mosquito control using genetically engineered males and Wolbachia-infected mosquitoes is already feasible, but that fragmented review processes in the United States slow adoption. Genetic methods that prevent female offspring from surviving differ from methods that use bacterial infection to suppress reproduction or reduce viral transmission. In a Singapore trial cited by the article, areas where male mosquitoes were released saw mosquito numbers fall by 85% and dengue infections by about 70%. These are results from a particular trial, not evidence that all mosquito-borne diseases can be eradicated. Product-specific approvals and local conditions need to be considered separately.